Therefore, a link between the dose–response parameters of insulin use might also reflect a link with progressive pathophysiological changes associated with increasing diabetes duration such as insulin resistance, inflammation, oxidative stress, and aggravated hyperglycemia. The gene discussed is INS; the disease is diabetes mellitus.